Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 128

1.

Type 3 renal tubular acidosis associated with growth hormone deficiency.

Liew YP, Rogers TA, Garb JL, Allen HF, Reiter EO, Campfield TJ, Dharnidharka VR, Braden GL.

J Pediatr Endocrinol Metab. 2017 Oct 26;30(10):1047-1053. doi: 10.1515/jpem-2016-0460.

PMID:
28888090
2.

A multicenter, open-label, observational study of testosterone gel (1%) in the treatment of adolescent boys with klinefelter syndrome or anorchia.

Rogol AD, Swerdloff RS, Reiter EO, Ross JL, ZumBrunnen TL, Pratt GA, Brennan JJ, Benesh J, Kan-Dobrosky N, Miller MG.

J Adolesc Health. 2014 Jan;54(1):20-5. doi: 10.1016/j.jadohealth.2013.07.021. Epub 2013 Sep 13.

PMID:
24035132
3.

Secondary sexual characteristics in boys: data from the Pediatric Research in Office Settings Network.

Herman-Giddens ME, Steffes J, Harris D, Slora E, Hussey M, Dowshen SA, Wasserman R, Serwint JR, Smitherman L, Reiter EO.

Pediatrics. 2012 Nov;130(5):e1058-68. doi: 10.1542/peds.2011-3291. Epub 2012 Oct 20.

PMID:
23085608
4.

Metabolic syndrome in obese adolescents is associated with risk for nephrolithiasis.

Tiwari R, Campfield T, Wittcopp C, Braden G, Visintainer P, Reiter EO, Allen HF.

J Pediatr. 2012 Apr;160(4):615-620.e2. doi: 10.1016/j.jpeds.2011.09.051. Epub 2011 Nov 17.

PMID:
22099686
5.

Bicalutamide plus anastrozole for the treatment of gonadotropin-independent precocious puberty in boys with testotoxicosis: a phase II, open-label pilot study (BATT).

Reiter EO, Mauras N, McCormick K, Kulshreshtha B, Amrhein J, De Luca F, O'Brien S, Armstrong J, Melezinkova H.

J Pediatr Endocrinol Metab. 2010 Oct;23(10):999-1009.

PMID:
21158211
6.

Results of a second year of therapy with the 12-month histrelin implant for the treatment of central precocious puberty.

Rahhal S, Clarke WL, Kletter GB, Lee PA, Neely EK, Reiter EO, Saenger P, Shulman D, Silverman L, Eugster EA.

Int J Pediatr Endocrinol. 2009;2009:812517. doi: 10.1155/2009/812517. Epub 2009 Feb 26.

7.

Metabolic abnormalities in human immunodeficiency virus-infected children: two-year follow-up.

Krause JC, Toye MP, Fisher DJ, Stechenberg BW, Reiter EO, Allen HF.

J Pediatr Endocrinol Metab. 2009 Apr;22(4):345-51.

PMID:
19554809
8.

Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop.

Cohen P, Rogol AD, Deal CL, Saenger P, Reiter EO, Ross JL, Chernausek SD, Savage MO, Wit JM; 2007 ISS Consensus Workshop participants.

J Clin Endocrinol Metab. 2008 Nov;93(11):4210-7. doi: 10.1210/jc.2008-0509. Epub 2008 Sep 9.

PMID:
18782877
9.

Public health implications of altered puberty timing.

Golub MS, Collman GW, Foster PM, Kimmel CA, Rajpert-De Meyts E, Reiter EO, Sharpe RM, Skakkebaek NE, Toppari J.

Pediatrics. 2008 Feb;121 Suppl 3:S218-30. doi: 10.1542/peds.2007-1813G. Review.

PMID:
18245514
10.

Idiopathic short stature: management and growth hormone treatment.

Wit JM, Reiter EO, Ross JL, Saenger PH, Savage MO, Rogol AD, Cohen P.

Growth Horm IGF Res. 2008 Apr;18(2):111-35. doi: 10.1016/j.ghir.2007.11.003. Epub 2008 Feb 21. Review.

PMID:
18178498
11.

Efficacy and safety of histrelin subdermal implant in children with central precocious puberty: a multicenter trial.

Eugster EA, Clarke W, Kletter GB, Lee PA, Neely EK, Reiter EO, Saenger P, Shulman D, Silverman L, Flood L, Gray W, Tierney D.

J Clin Endocrinol Metab. 2007 May;92(5):1697-704. Epub 2007 Feb 27.

PMID:
17327379
12.

Small for gestational age: short stature and beyond.

Saenger P, Czernichow P, Hughes I, Reiter EO.

Endocr Rev. 2007 Apr;28(2):219-51. Epub 2007 Feb 23. Review.

PMID:
17322454
13.

Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.

Ranke MB, Lindberg A, Price DA, Darendeliler F, Albertsson-Wikland K, Wilton P, Reiter EO; KIGS International Board.

Horm Res. 2007;68(2):53-62. Epub 2007 Jan 16.

PMID:
17228181
14.

Major determinants of height development in Turner syndrome (TS) patients treated with GH: analysis of 987 patients from KIGS.

Ranke MB, Lindberg A, Ferrández Longás A, Darendeliler F, Albertsson-Wikland K, Dunger D, Cutfield WS, Tauber M, Wilton P, Wollmann HA, Reiter EO; KIGS International Board.

Pediatr Res. 2007 Jan;61(1):105-10.

PMID:
17211150
15.

Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database).

Craig ME, Cowell CT, Larsson P, Zipf WB, Reiter EO, Albertsson Wikland K, Ranke MB, Price DA; KIGS International Board.

Clin Endocrinol (Oxf). 2006 Aug;65(2):178-85.

PMID:
16886957
17.

Effect of growth hormone (GH) treatment on the near-final height of 1258 patients with idiopathic GH deficiency: analysis of a large international database.

Reiter EO, Price DA, Wilton P, Albertsson-Wikland K, Ranke MB.

J Clin Endocrinol Metab. 2006 Jun;91(6):2047-54. Epub 2006 Mar 14.

PMID:
16537676
18.

HIV--associated lipodystrophy in children.

Krause JC, Toye MP, Stechenberg BW, Reiter EO, Allen HF.

Pediatr Endocrinol Rev. 2005 Sep;3(1):45-51. Review.

PMID:
16369213
19.

Testotoxicosis: current viewpoint.

Reiter EO, Norjavaara E.

Pediatr Endocrinol Rev. 2005 Dec;3(2):77-86. Review.

PMID:
16361981
20.

Randomized controlled trial evaluating response to metformin versus standard therapy in the treatment of adolescents with polycystic ovary syndrome.

Allen HF, Mazzoni C, Heptulla RA, Murray MA, Miller N, Koenigs L, Reiter EO.

J Pediatr Endocrinol Metab. 2005 Aug;18(8):761-8.

PMID:
16200842
21.

Final height in children with medulloblastoma treated with growth hormone.

Ranke MB, Price DA, Lindberg A, Wilton P, Darendeliler F, Reiter EO.

Horm Res. 2005;64(1):28-34. Epub 2005 Aug 11.

22.

Insulin-like growth factors as diagnostic tools in growth hormone deficiency during childhood and adolescence: the KIGS experience.

Ranke MB, Schweizer R, Lindberg A, Price DA, Reiter EO, Albertsson-Wikland K, Darendeliler F.

Horm Res. 2004;62 Suppl 1:17-25. Erratum in: Horm Res. 2005;63(4):210. Darendelliler, Feyza [corrected to Darendeliler, Feyza].

PMID:
15761228
23.

Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.

Ranke MB, Lindberg A, Albertsson-Wikland K, Wilton P, Price DA, Reiter EO.

J Clin Endocrinol Metab. 2005 Apr;90(4):1966-71. Epub 2005 Jan 5.

PMID:
15634724
25.

Safety and efficacy of anastrozole for the treatment of pubertal gynecomastia: a randomized, double-blind, placebo-controlled trial.

Plourde PV, Reiter EO, Jou HC, Desrochers PE, Rubin SD, Bercu BB, Diamond FB Jr, Backeljauw PF.

J Clin Endocrinol Metab. 2004 Sep;89(9):4428-33.

PMID:
15356042
26.

Pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient children.

Kemp SF, Fielder PJ, Attie KM, Blethen SL, Reiter EO, Ford KM, Marian M, Dao LN, Lee HJ, Saenger P.

J Clin Endocrinol Metab. 2004 Jul;89(7):3234-40.

PMID:
15240597
27.

Continuous glucose monitoring in children with type 1 diabetes: before and after insulin pump therapy.

Heptulla RA, Allen HF, Gross TM, Reiter EO.

Pediatr Diabetes. 2004 Mar;5(1):10-5.

PMID:
15043684
28.

Personnel costs and perceived benefit of telephone care in the management of children with type 1 diabetes.

Allen HF, Yarnie S, Murray MA, Reiter EO.

Pediatr Diabetes. 2002 Jun;3(2):95-100.

PMID:
15016163
29.

The mathematical model for total pubertal growth in idiopathic growth hormone (GH) deficiency suggests a moderate role of GH dose.

Ranke MB, Lindberg A, Martin DD, Bakker B, Wilton P, Albertsson-Wikland K, Cowell CT, Price DA, Reiter EO.

J Clin Endocrinol Metab. 2003 Oct;88(10):4748-53.

PMID:
14557450
30.

The KIGS experience with the addition of gonadotropin-releasing hormone agonists to growth hormone (GH) treatment of children with idiopathic GH deficiency.

Reiter EO, Lindberg A, Ranke MB, Price DA, Albertsson-Wikland K, Cowell CT, Bakker B.

Horm Res. 2003;60(Suppl 1):68-73.

31.

Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial.

Eugster EA, Rubin SD, Reiter EO, Plourde P, Jou HC, Pescovitz OH; McCune-Albright Study Group.

J Pediatr. 2003 Jul;143(1):60-6.

PMID:
12915825
32.

Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia International Growth Database).

Ranke MB, Lindberg A, Cowell CT, Wikland KA, Reiter EO, Wilton P, Price DA; KIGS International Board.

J Clin Endocrinol Metab. 2003 Jan;88(1):125-31.

PMID:
12519840
33.

A growth prediction model for short children born small for gestational age.

Ranke MB, Cutfield WS, Lindberg A, Cowell CT, Albertsson-Wikland K, Reiter EO, Wilton P, Price DA; KIGS International Board.

J Pediatr Endocrinol Metab. 2002 Dec;15 Suppl 5:1273. No abstract available.

PMID:
12510978
34.

Work group I: developing models of healthy adolescent physical development.

Susman EJ, Reiter EO, Ford C, Dorn LD.

J Adolesc Health. 2002 Dec;31(6 Suppl):171-4. No abstract available.

PMID:
12470912
35.

Normal progression of testicular size in boys with idiopathic short stature and isolated growth hormone deficiency treated with growth hormone: experience from the KIGS.

Lindgren AC, Chatelain P, Lindberg A, Price DA, Ranke MB, Reiter EO, Wilton P; KIGS International Board.

Horm Res. 2002;58(2):83-7.

PMID:
12207167
36.

A long-acting human growth hormone (Nutropin Depot): efficacy and safety following two years of treatment in children with growth hormone deficiency.

Silverman BL, Blethen SL, Reiter EO, Attie KM, Neuwirth RB, Ford KM.

J Pediatr Endocrinol Metab. 2002 May;15 Suppl 2:715-22.

PMID:
12092685
37.

Genital size: a common adolescent male concern.

Lee PA, Reiter EO.

Adolesc Med. 2002 Feb;13(1):171-80, viii. Review.

PMID:
11841963
38.

Delayed puberty.

Reiter EO, Lee PA.

Adolesc Med. 2002 Feb;13(1):101-18, vii. Review.

PMID:
11841958
39.

Educated?... For uncertainty.

Reiter EO.

J Pediatr Endocrinol Metab. 2002 Jan;15(1):3-4. No abstract available.

PMID:
11822576
40.

A multicenter study of the efficacy and safety of sustained release GH in the treatment of naive pediatric patients with GH deficiency.

Reiter EO, Attie KM, Moshang T Jr, Silverman BL, Kemp SF, Neuwirth RB, Ford KM, Saenger P; Genentech, Inc.-Alkermes, Inc. Collaborative Study Group.

J Clin Endocrinol Metab. 2001 Oct;86(10):4700-6.

PMID:
11600528
41.

Outcome of growth hormone therapy in children with growth hormone deficiency showing an inadequate response to growth hormone-releasing hormone.

Saenger P, Pescovitz OH, Bercu BB, Murray FT, Landy H, Brentzel J, O'Dea L, Hanson B, Howard C, Reiter EO; Geref International Study Group.

Endocrine. 2001 Jun;15(1):51-6.

PMID:
11572326
42.

Growth hormone: new ideas, recurring themes.

Reiter EO.

Endocrine. 2001 Jun;15(1):1-4. Review. No abstract available.

PMID:
11572315
43.

Have the onset and tempo of puberty changed?

Reiter EO, Lee PA.

Arch Pediatr Adolesc Med. 2001 Sep;155(9):988-9. No abstract available.

PMID:
11529797
44.

Early initiation of growth hormone treatment allows age-appropriate estrogen use in Turner's syndrome.

Reiter EO, Blethen SL, Baptista J, Price L.

J Clin Endocrinol Metab. 2001 May;86(5):1936-41.

PMID:
11344188
46.

Diverse deletions in the growth hormone receptor gene cause growth hormone insensitivity syndrome.

Gastier JM, Berg MA, Vesterhus P, Reiter EO, Francke U.

Hum Mutat. 2000 Oct;16(4):323-33.

PMID:
11013443
47.

Four contiguous amino acid substitutions, identified in patients with Laron syndrome, differently affect the binding affinity and intracellular trafficking of the growth hormone receptor.

Wojcik J, Berg MA, Esposito N, Geffner ME, Sakati N, Reiter EO, Dower S, Francke U, Postel-Vinay MC, Finidori J.

J Clin Endocrinol Metab. 1998 Dec;83(12):4481-9.

PMID:
9851797
48.

Y Chromosomal Sequences Identified in Gonadal Tissue of Two 45,X Patients with Turner Syndrome.

Kocova M, Witchel SF, Nalesnik M, Lee PA, Dickman PS, MacGillivray MH, Reiter EO, Trucco G, Trucco M.

Endocr Pathol. 1995 Winter;6(4):311-322.

PMID:
12114813
49.

Serum bioactive luteinizing and follicle-stimulating hormone concentrations in girls increase during puberty.

Kasa-Vubu JZ, Padmanabhan V, Kletter GB, Brown MB, Reiter EO, Sizonenko PC, Beitins IZ.

Pediatr Res. 1993 Dec;34(6):829-33.

PMID:
8108202
50.

Serum bioactive gonadotropins during male puberty: a longitudinal study.

Kletter GB, Padmanabhan V, Brown MB, Reiter EO, Sizonenko PC, Beitins IZ.

J Clin Endocrinol Metab. 1993 Feb;76(2):432-8.

PMID:
8432787

Supplemental Content

Loading ...
Support Center